Comparative Pharmacology
Head-to-head clinical analysis: INTRALIPID 10 versus LIPOSYN III 20.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INTRALIPID 10 versus LIPOSYN III 20.
INTRALIPID 10% vs LIPOSYN III 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intralipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of energy. It acts as a carrier for fat-soluble vitamins and prevents essential fatty acid deficiency. The mechanism involves direct utilization of triglycerides for energy after hydrolysis by lipoprotein lipase.
Liposyn III 20% is a lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories. It serves as a source of energy and prevents essential fatty acid deficiency by supplying triglycerides that are hydrolyzed to free fatty acids and glycerol for metabolism.
Intravenous infusion. Adult: 500 mL of 10% emulsion (50 g fat) over 4-6 hours, up to 2.5 g fat/kg/day. Maximum infusion rate: 0.1 g fat/kg/hour.
Adults: 500 mL to 2500 mL per day via continuous intravenous infusion (including peripheral or central vein); typical rate: 0.5-1 mL/kg/h initially, increasing to 1.5-2 mL/kg/h as tolerated. Maximum infusion rate: 2.5 mL/kg/h.
None Documented
None Documented
The terminal elimination half-life of Intralipid triglycerides is approximately 30-60 minutes in adults with normal lipid metabolism. In neonates and patients with impaired clearance, half-life may be prolonged to 2-4 hours. Clinical context: half-life increases with infusion rate; at steady state, clearance is rapid due to extrahepatic lipolysis.
The terminal elimination half-life of infused triglycerides is approximately 0.5–1 h (33–60 min). Clearance is saturable; at high infusion rates, half-life may prolong.
Intralipid 10% (IV fat emulsion) is metabolized like endogenous chylomicrons; elimination is not via renal or biliary routes. Triglycerides are hydrolyzed by lipoprotein lipase, and the resulting free fatty acids are taken up by tissues. Less than 0.5% is excreted unchanged in urine. Biliary excretion of metabolites is negligible.
Primarily eliminated via endogenous lipid metabolic pathways (beta-oxidation in tissues). <5% excreted unchanged in urine; minimal biliary/fecal elimination.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion